168 research outputs found

    Healthcare technologies and professional vision

    Get PDF
    This paper presents some details from an observational evaluation of a computer assisted detection tool in mammography. The use of the tool, its strengths and weaknesses, are documented and its impact on reader's 'professional vision' (Goodwin 1994) considered. The paper suggests issues for the design, use and, importantly, evaluation of new technologies in everyday medical work, pointing to general issues concerning trust – users’ perception of the dependability of the evidence generated by such tools and suggesting that evaluations require an emphasis on the complex issue of what technologies afford their users in everyday work

    Abstractions, accounts and grid usability

    Get PDF
    The vision of the Grid is one of seamless, virtual and constantly changing resources where users need not concern themselves about details, such as exactly where an application is running or where their data is being stored. However, seamless and virtual often imply a lack of control that users may be wary of, or even opposed to. Drawing upon our studies of HCI and of collaborative work, this paper examines whether the Grid development community should be taking this vision literally and argues for the need for accountability of systems ‘in interaction’. We give examples of an alternative approach that seeks to provide ways in which administrators, technical support and user communities can make sense of the behaviour of the complex socio-technical ensembles that are the reality of Grids

    Summative Evaluation Plan - Project StORe

    Get PDF
    To evaluate the demonstrator system and project ‘common model’ in order to make recommendations for future development work. The evaluation will assess the technical structure, functionality, design and quality of the demonstrator system, and the appropriateness of the ‘common model’ approach, using workshops to test the system with representative repository users

    User-centered development of a Virtual Research Environment to support collaborative research events

    Get PDF
    This paper discusses the user-centred development process within the Collaborative Research Events on the Web (CREW) project, funded under the JISC Virtual Research Environments (VRE) programme. After presenting the project, its aims and the functionality of the CREW VRE, we focus on the user engagement approach, grounded in the method of co-realisation. We describe the different research settings and requirements of our three embedded user groups and the respective activities conducted so far. Finally we elaborate on the main challenges of our user engagement approach and end with the project’s next steps

    Manipulating the Incorporation of [1- 14

    Full text link

    Managing the trade-off implications of global supply

    Get PDF
    The cost versus response trade-off is a growing logistics issue due to many markets being increasingly characterized by demand uncertainty and shorter product life cycles. This is exacerbated further with supply increasingly moving to low cost global sources. However, the poor response implications of global supply are often not addressed or even acknowledged when undertaking such decisions. Consequently, various practical approaches to minimising, postponing or otherwise managing the impact of the demand uncertainty are often only adopted retrospectively. Even though such generic solutions are documented through case examples we lack effective tools and concepts to support the proactive identification and resolution of such trade-offs. This paper reports on case-based theory building research, involving three cases from the UK and USA used in developing a conceptual model with associated tools, in support of such a process

    Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies

    Get PDF
    Ebola virus (EBOV) is an enveloped, single-stranded RNA virus that can cause Ebola virus disease (EVD). It is thought that EVD survivors are protected against subsequent infection with EBOV and that neutralising antibodies to the viral surface glycoprotein (GP) are potential correlates of protection. Serological studies are vital to assess neutralising antibodies targeted to EBOV GP; however, handling of EBOV is limited to containment level 4 laboratories. Pseudotyped viruses can be used as alternatives to live viruses, which require high levels of bio-containment, in serological and viral entry assays. However, neutralisation capacity can differ among pseudotyped virus platforms. We evaluated the suitability of EBOV GP pseudotyped human immunodeficiency virus type 1 (HIV-1) and vesicular stomatitis virus (VSV) to measure the neutralising ability of plasma from EVD survivors, when compared to results from a live EBOV neutralisation assay. The sensitivity, specificity and correlation with live EBOV neutralisation were greater for the VSV-based pseudotyped virus system, which is particularly important when evaluating EBOV vaccine responses and immuno-therapeutics. Therefore, the EBOV GP pseudotyped VSV neutralisation assay reported here could be used to provide a better understanding of the putative correlates of protection against EBOV

    Investigating the effect of ribavirin treatment on genetic mutations in Crimean-Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing.

    Get PDF
    Crimean-Congo haemorrhagic fever (CCHF) is the most widespread tick-borne viral haemorrhagic fever affecting humans, and yet a licensed drug against the virus (CCHFV) is still not available. While several studies have suggested the efficacy of ribavirin against CCHFV, current literature remains inconclusive. In this study, we have utilised next-generation sequencing to investigate the mutagenic effect of ribavirin on the CCHFV genome during clinical disease. Samples collected from CCHF patients receiving ribavirin treatment or supportive care only at Sivas Cumhuriyet University Hospital, Turkey, were analysed. By comparing the frequency of mutations in each group, we found little evidence of an overall mutagenic effect. This suggests that ribavirin, administered at the acute stages of CCHFV infection (at the World Health Organization-recommended dose) is unable to induce lethal mutagenesis that would cause an extinction event in the CCHFV population and reduce viremia
    • …
    corecore